Filtros de búsqueda

Lista de obras de

Activity of BET-proteolysis targeting chimeric (PROTAC) compounds in triple negative breast cancer

artículo científico publicado en 2019

BET inhibitors as novel therapeutic agents in breast cancer.

artículo científico publicado en 2017

DNA-damage related genes and clinical outcome in hormone receptor positive breast cancer

artículo científico publicado en 2016

Evaluation of transcriptionally regulated genes identifies NCOR1 in hormone receptor negative breast tumors and lung adenocarcinomas as a potential tumor suppressor gene

artículo científico publicado en 2018

Expression of MHC class I, HLA-A and HLA-B identifies immune-activated breast tumors with favorable outcome

artículo científico publicado en 2019

Genetic mutational status of genes regulating epigenetics: Role of the histone methyltransferase KMT2D in triple negative breast tumors

article

In silico analyses identify gene-sets, associated with clinical outcome in ovarian cancer: role of mitotic kinases.

artículo científico publicado en 2016

Mapping Bromodomains in breast cancer and association with clinical outcome

scientific article published on 05 April 2019

Mitotic read-out genes confer poor outcome in luminal A breast cancer tumors.

artículo científico publicado en 2017

Neutrophils in cancer: prognostic role and therapeutic strategies.

artículo científico publicado en 2017

Poly(Cyclohexene Phthalate) Nanoparticles for Controlled Dasatinib Delivery in Breast Cancer Therapy

scientific article published on 27 August 2019

Screening and Preliminary Biochemical and Biological Studies of [RuCl(p-cymene)(N,N-bis(diphenylphosphino)-isopropylamine)][BF4] in Breast Cancer Models

artículo científico publicado en 2019

Synthetic lethality interaction between Aurora kinases and CHEK1 inhibitors in ovarian cancer.

artículo científico

Targeting basal-like breast tumors with bromodomain and extraterminal domain (BET) and polo-like kinase inhibitors

artículo científico publicado en 2017

Trastuzumab-Targeted Biodegradable Nanoparticles for Enhanced Delivery of Dasatinib in HER2+ Metastasic Breast Cancer

artículo científico publicado en 2019

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda